-
ELOX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of ELOX shares has decreased $0.01 since the market last closed. This is a 0.09% drop.
-
Closed at $11.00.
The stock has since dropped $0.22 in after-hours trading.
Key terms
About ELOX
Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
-
Market cap: $461.73K
A market capitalization up to $300 million places ELOX in the micro-capitalization category.
Key terms
Smart score
Latest ELOX news
No recent TipRanks articles are available for ELOX
No recent press releases are available for ELOX
ELOX Financials
-
ELOX total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$36.06M (1Y), -$3.75M (Q1)
Net Income increased 45.95% since last year and increased 40.59% since last quarter.
-
Earnings per share: -$183.13 (1Y), -$0.86 (Q1)
EPS increased 56.36% since last year and increased 97.33% since last quarter.
Key terms
ELOX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ELOX Competitors
-
How competitors are chosen
ELOX's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $461.73K
A market capitalization up to $300 million places ELOX in the micro-capitalization category.
